Previous work has demonstrated that unlike other tumor markers, which are expressed in situ, CD137 can be additionally upregulated on tumor-reactive T cells after tumor digestion presumably due to TCR mediated recognition of peptide-MHC complexes on tumor cells during the co-culture (23). Here, TNFRSF9 is linked to neoplasm.